Urgent Care Centers Thrive As Potential Solution to Physician Crunch

Urgent Care Centers Thrive As Potential Solution to Physician Crunch

The Urgent Care Industry is prospering for a good reason. There is more demand for doctors than there is supply. But how many urgent care centers are there in the U.S.? And what is the growth trend for urgent cares. We look at these questions and also talk about the challenges facing the urgent care business model.


Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

The 21st Century Cures Act was broadly supported in the U.S. Congress for its various provisions, including increased funding for cancer research and the revision of U.S. Food and Drug Administration (FDA) standards for review. The Act authorized $4.8 billion over the next 10 years for cancer research under the Moonshot Initiative, the Precision Medicine Initiative (PMI) and FDA regulatory reform. Appropriation of those funds may prove newly problematic in light of the White House administration’s disclosed budget priorities.


What are the Growth Markets in the Hospital Infection Control Industry?

What are the Growth Markets in the Hospital Infection Control Industry?

The scourge of hospital-acquired-infections (HAIs) will drive market growth for infection control in three segments. Devices that can test for HAIs, equipment to clean and sterilize facilities and devices, and drugs that can treat these threats.


How Big is the Point-of-Care Diagnostics Market? $18 Billion and Climbing

Our new report finds lots of activity and opportunity in near patient testing. The POC diagnostic industry is part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine as emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the POC landscape. New technologies are making the concept more viable than ever.

  • by Emil Salazar
  • March 8 2017


Current State of the Molecular Transplant Diagnostics Market

Current State of the Molecular Transplant Diagnostics Market

The global market for molecular transplant diagnostics is projected by Kalorama Information to grow in the high single digits each year through 2021. In The World Market for Molecular Diagnostics, 7th Edition, Kalorama identifies bone marrow transplants and high-resolution tissue typing methods as key drivers for the molecular diagnostics market segment. As in other molecular diagnostics areas, established molecular methods for tissue typing face mounting competition from next-generation sequencing (NGS)-based methods.


Big Developments in NGS Market: Assay Kits Appear

Big Developments in NGS Market: Assay Kits Appear

Most sequencing tests performed for clinical applications in the U.S. are laboratory developed tests (LDTs), according to Kalorama Information, meaning that the serviced is performed by test manufacturer and results sent to lab clients. But this is changing, and some of those changes have happened in the last three months. Kalorama Information covers sequencing markets in its report, Next-Generation Sequencing Markets.


Test Guidelines Positive News for Cancer MDx Market

Test Guidelines Positive News for Cancer MDx Market

New guidelines on the use of biomarker-based tests for colorectal cancer are welcome news for test developers. We cover molecular-based cancer assays in our new report, The World Market for Molecular Diagnostics, 7th Edition.

  • by Bruce Carlson
  • February 27 2017
  • EMR


Round-Up of HIMSS 2017

Round-Up of HIMSS 2017

Artificial Intelligence, Obamacare repeal, new offers and greater integration was on display at HIMSS 2017 in Orlando, according to the analyst of our EMR Market report, Mary Anne Crandall, who reported on events.

  • by Bruce Carlson
  • February 22 2017


Ultrasound Market: Favorable Trends Abound

Ultrasound Market: Favorable Trends Abound

The ultrasound market is growing driven by several trends. Here we discuss a few of them. Prehospital use, volumetric imaging, speckle reduction, mobility, and improvements in cardiac ultrasound are among the trends driving the market noted in Kalorama’s most recent edition of Ultrasound Markets.

  • by Emil Salazar
  • February 21 2017


Challenged for Growth, Nucleic Acid Test Vendors Target New Threats to Global Blood Supply

Challenged for Growth, Nucleic Acid Test Vendors Target New Threats to Global Blood Supply

The market for nucleic acid tests (NAT) used in blood donation screening is constrained by stagnant or declining transfusion rates in the developed world. Achieving business growth is challenging even for the largest IVD players. Competitive displacement, in the form of contract wins with blood organizations, is the most prominent strategy for growth, but is reliant upon vendors’ responsiveness to new transfusion transmitted infection (TTI) threats.